We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 370 results
  1. Modern therapies of nonsmall cell lung cancer

    Lung cancer (LC), particularly nonsmall cell lung cancer (NSCLC), is one of the most prevalent types of neoplasia worldwide, regardless of gender,...

    Andrzej Jachowski, Mikołaj Marcinkowski, ... Bartosz Kazimierz Słowikowski in Journal of Applied Genetics
    Article Open access 12 September 2023
  2. A local human Vδ1 T cell population is associated with survival in nonsmall-cell lung cancer

    Murine tissues harbor signature γδ T cell compartments with profound yet differential impacts on carcinogenesis. Conversely, human tissue-resident γδ...

    Yin Wu, Dhruva Biswas, ... Charles Swanton in Nature Cancer
    Article Open access 30 May 2022
  3. Knockdown of growth differentiation factor-15 inhibited nonsmall cell lung cancer through inactivating PTEN/PI3K/AKT signaling pathway

    Background

    Non-small cell lung cancer (NSCLC) is characterized by high morbidity and mortality in the world. Growth and differentiation factor 15...

    Yongshi Liu, Jie Lei, ... Yan Li in Genes & Genomics
    Article 28 October 2022
  4. Double homeobox a pseudogene 8/miR-223-3p/PFN2 modulates radiosensitivity in lung cancer

    Background

    Long noncoding RNA double homeobox A pseudogene 8 (DUXAP8) was revealed to facilitate lung cancer progression in vitro, but the impacts of...

    Chong Pang, Tengyue Zhang, ... Changli Wang in Molecular & Cellular Toxicology
    Article 26 June 2023
  5. PLEKHH2 binds β-arrestin1 through its FERM domain, activates FAK/PI3K/AKT phosphorylation, and promotes the malignant phenotype of non-small cell lung cancer

    PLEKHH2 is an important FERM domain containing-protein. However, the role of PLEKHH2 in human solid tumors has not been reported yet. We report that...

    Rui Wang, Si Wang, ... Yang Liu in Cell Death & Disease
    Article Open access 08 October 2022
  6. Future Perspectives of Exosomal Payload of miRNAs in Lung Cancer

    Exosomes are nanovesicles, which were first described in 1983 as a method by which cells disposed of their metabolic waste. Since the publication of...
    Beatrice Aramini, Valentina Masciale, ... Khawaja Husnain Haider in Handbook of Stem Cell Therapy
    Living reference work entry 2022
  7. Future Perspectives of Exosomal Payload of miRNAs in Lung Cancer

    Exosomes are nanovesicles, which were first described in 1983 as a method by which cells disposed of their metabolic waste. Since the publication of...
    Beatrice Aramini, Valentina Masciale, ... Khawaja Husnain Haider in Handbook of Stem Cell Therapy
    Reference work entry 2022
  8. Cannabis and Cancer

    The International Agency for Research on Cancer report on the global burden of cancer estimated 18.1 million new cancer cases (17.0 million excluding...
    Chapter 2023
  9. CXCR4 uses STAT3-mediated slug expression to maintain radioresistance of non-small cell lung cancer cells: emerges as a potential prognostic biomarker for lung cancer

    Lung cancer is one of the most common reasons for cancer-induced mortality across the globe, despite major advancements in the treatment strategies...

    Jeong-Yub Kim, Hee-** Kim, ... Myung-** Park in Cell Death & Disease
    Article Open access 07 January 2021
  10. Regulome-based characterization of drug activity across the human diseasome

    Drugs are expected to recover the cell system away from the impaired state to normalcy through disease treatment. However, the understanding of gene...

    Michio Iwata, Keisuke Kosai, ... Yoshihiro Yamanishi in npj Systems Biology and Applications
    Article Open access 07 November 2022
  11. Peripheral CD4+ T cell signatures in predicting the responses to anti-PD-1/PD-L1 monotherapy for Chinese advanced non-small cell lung cancer

    Limited benefit population of immune checkpoint inhibitors makes it urgent to screen predictive biomarkers for stratifying the patients. Herein, we...

    Liliang **a, Hui Wang, ... Ying Wang in Science China Life Sciences
    Article 29 January 2021
  12. Protein–Protein Interactions in Cancer

    Cancerous state is often associated with the aberrant expression of several critical proteins, which in turn, modulate interactions with other...
    Krishna Mohan Poluri, Khushboo Gulati, ... Nupur Nagar in Protein-Protein Interactions
    Chapter 2023
  13. Ferroptosis as a potential target for cancer therapy

    Ferroptosis is a recently discovered essential type of cell death that is mainly characterized by iron overload and lipid peroxidation. Emerging...

    Zhen Chen, Weilong Wang, ... **umin Li in Cell Death & Disease
    Article Open access 24 July 2023
  14. Coculture with macrophages alters ferroptosis susceptibility of triple-negative cancer cells

    Various treatment options, such as molecular targeted drugs and immune checkpoint blockades, are available for patients with cancer. However, some...

    Hiroto Konishi, Yuya Haga, ... Yasuo Tsutsumi in Cell Death Discovery
    Article Open access 01 March 2024
  15. A glimpse into novel acylations and their emerging role in regulating cancer metastasis

    Metastatic cancer is a major cause of cancer-related mortality; however, the complex regulation process remains to be further elucidated. A large...

    Huifang Shi, Weigang Cui, ... Jie Lv in Cellular and Molecular Life Sciences
    Article Open access 05 February 2024
  16. ULK1 inhibition overcomes compromised antigen presentation and restores antitumor immunity in LKB1-mutant lung cancer

    Inactivating mutations in LKB1/STK11 are present in roughly 20% of nonsmall cell lung cancers (NSCLC) and portend poor response to anti-PD-1...

    Jiehui Deng, Aatish Thennavan, ... Kwok-Kin Wong in Nature Cancer
    Article 17 May 2021
  17. Sirtuin 6 Is a Critical Epigenetic Regulator of Cancer

    Sirtuin 6 (SIRT6) is a member of the mammalian sirtuin family with deacetylase, deacylase, and mono-ADP-ribosyl-transferase activities. It is a...
    Sukanya Raghu, Arathi Bangalore Prabhashankar, ... Nagalingam Ravi Sundaresan in Metabolism and Epigenetic Regulation: Implications in Cancer
    Chapter 2022
  18. Treatment of Cancer Using Combination of Herbal and Novel Drug Delivery System

    Nanotechnology and nanoengineering tend to generate significant scientific and technological push on in diverse domain including medicine and...
    Chapter 2023
  19. Long noncoding RNA LINC00518 contributes to proliferation and metastasis in lung adenocarcinoma via the miR-335-3p/CTHRC1 Axis

    Long intergenic nonprotein coding RNA 518 (LINC00518) is recognized to impart cancer proliferation and metastasis in lung adenocarcinoma (LUAD)....

    Ruoyi Shen, **n Cai, ... Jian-an Huang in Cell Death Discovery
    Article Open access 04 March 2022
  20. Regulation of IL33 Gene Expression by SP1 and Foxa1 in Breast and Lung Cancer Cells

    Abstract

    Interleukin-33 (IL-33) is a member of the IL-1 cytokine family, primarily known as a mediator of the humoral immune response. It provides...

    A. M. Gorbacheva, D. V. Kuprash, N. A. Mitkin in Molecular Biology
    Article 01 January 2021
Did you find what you were looking for? Share feedback.